激素性股骨头坏死(steroid-induced necrosis of the femoral head, SNOFH)是骨科常见难治性疾病,又被视为“不死癌症”,若不及时干预将导致患者面临人工全髋关节置换术的风险。近些年研究证实,“成骨-成血管耦联”途径研究SNOFH发生发...激素性股骨头坏死(steroid-induced necrosis of the femoral head, SNOFH)是骨科常见难治性疾病,又被视为“不死癌症”,若不及时干预将导致患者面临人工全髋关节置换术的风险。近些年研究证实,“成骨-成血管耦联”途径研究SNOFH发生发展的机制具有重要意义。SNOFH中医病机责之于脾肾亏虚为本,瘀血为病,痰阻为渐,毒聚为损。“成骨-成血管耦联”机制与“瘀去-新生-骨合”中医理论存在高度契合性。越来越多的临床证据表明中医药治疗SNOFH不仅具有疗效显著、不良反应小、价格低廉等优势,还能提高患者生存质量,为促进股骨头血管重建与再生以及股骨头坏死骨修复等发挥重要作用。基于“瘀去-新生-骨合”理论,临床上多采用补肾活血类中药及中药复方用于SNOFH防治,运用“成骨”之健脾补肾药,“成血管”之活血化瘀药,祛除“抑制因素”之化痰药、祛湿药,有步骤、有层次的治疗SNOFH取得显著效果。因此,从“成骨-成血管耦联”角度探讨SNOFH中医药干预的科学内涵已成为当今研究新热点,能够为后续SNOFH的防治研究和新药研发提供理论参考和借鉴。展开更多
降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)是一种由感觉神经纤维合成释放的生物活性肽类物质之一。通过与CGRP受体复合物结合发挥血管扩张、疼痛传导等生理功能。已证实的降钙素基因相关肽拮抗剂有缓解偏头痛的能力,是...降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)是一种由感觉神经纤维合成释放的生物活性肽类物质之一。通过与CGRP受体复合物结合发挥血管扩张、疼痛传导等生理功能。已证实的降钙素基因相关肽拮抗剂有缓解偏头痛的能力,是目前偏头痛相关药物开发的热点。但近年来,降钙素基因相关肽对骨稳态的调节作用已引起广泛关注,本文就CGRP合成释放及其在骨稳态中的作用的研究进展进行作一综述。Calcitonin gene-related peptide (CGRP) is one of the bioactive peptides released by sensory nerve fibers. It plays physiological functions such as vascular dilation and pain conduction by binding with the CGRP receptor complex. It has been proven that calcitonin gene-related peptide antagonists have the ability to relieve migraine and are currently hot spots for migraine-related drug development. However, in recent years, the regulatory effect of calcitonin gene-related peptides on bone homeostasis has attracted much attention. This paper summarizes the CGRP synthesis and its role in bone homeostasis.展开更多
文摘激素性股骨头坏死(steroid-induced necrosis of the femoral head, SNOFH)是骨科常见难治性疾病,又被视为“不死癌症”,若不及时干预将导致患者面临人工全髋关节置换术的风险。近些年研究证实,“成骨-成血管耦联”途径研究SNOFH发生发展的机制具有重要意义。SNOFH中医病机责之于脾肾亏虚为本,瘀血为病,痰阻为渐,毒聚为损。“成骨-成血管耦联”机制与“瘀去-新生-骨合”中医理论存在高度契合性。越来越多的临床证据表明中医药治疗SNOFH不仅具有疗效显著、不良反应小、价格低廉等优势,还能提高患者生存质量,为促进股骨头血管重建与再生以及股骨头坏死骨修复等发挥重要作用。基于“瘀去-新生-骨合”理论,临床上多采用补肾活血类中药及中药复方用于SNOFH防治,运用“成骨”之健脾补肾药,“成血管”之活血化瘀药,祛除“抑制因素”之化痰药、祛湿药,有步骤、有层次的治疗SNOFH取得显著效果。因此,从“成骨-成血管耦联”角度探讨SNOFH中医药干预的科学内涵已成为当今研究新热点,能够为后续SNOFH的防治研究和新药研发提供理论参考和借鉴。
文摘降钙素基因相关肽(Calcitonin gene-related peptide, CGRP)是一种由感觉神经纤维合成释放的生物活性肽类物质之一。通过与CGRP受体复合物结合发挥血管扩张、疼痛传导等生理功能。已证实的降钙素基因相关肽拮抗剂有缓解偏头痛的能力,是目前偏头痛相关药物开发的热点。但近年来,降钙素基因相关肽对骨稳态的调节作用已引起广泛关注,本文就CGRP合成释放及其在骨稳态中的作用的研究进展进行作一综述。Calcitonin gene-related peptide (CGRP) is one of the bioactive peptides released by sensory nerve fibers. It plays physiological functions such as vascular dilation and pain conduction by binding with the CGRP receptor complex. It has been proven that calcitonin gene-related peptide antagonists have the ability to relieve migraine and are currently hot spots for migraine-related drug development. However, in recent years, the regulatory effect of calcitonin gene-related peptides on bone homeostasis has attracted much attention. This paper summarizes the CGRP synthesis and its role in bone homeostasis.